16 October 2024
Gepotidacin accepted for priority review by US FDA for treatment of uncomplicated urinary tract infections in female adults and adolescents GSK plc (LSE/NYSE: GSK)…
16 October 2024 Games Workshop Group PLC (the “Company”) DIVIDEND The Board has today declared a dividend of 85 pence per share taking dividends…
On Tuesday 15th October, ASML Holding NV (ASML) has published its 2024 third-quarter results. (Figures in millions of euros unless otherwise indicated) Q2 2024…
15 October 2024
15 October 2024 RUFFER INVESTMENT COMPANY LIMITED (a closed-ended investment company incorporated in Guernsey with registration number 41966) (the “Company“) Attached is a link…
14 October 2024
14 October 2024 B.P. Marsh & Partners Plc (“B.P. Marsh”, “the Company” or “the Group”) New Investment – Volt UW HoldCo Ltd (“Volt”) B.P. Marsh…
14 October 2024 LONDONMETRIC PROPERTY PLC Occupational activity adds £8.5 million of annual rental income LondonMetric Property Plc (“LondonMetric” or “Company”) announces an update…
GSK announces positive phase III results from ANCHOR trials for depemokimab in chronic rhinosinusitis with nasal polyps · Primary endpoints met with statistically significant reduction in…
10 October 2024
10 October 2024 TREATT PLC (“Treatt” or “the Group”) Trading update for the year ended 30 September 2024 Strong H2 momentum with full year…